Engineering human multi-organ tissue chip niches for drug absorption, distribution, metabolism, excretion and toxicity prediction
Multi-organ chips may improve drug predictions, but preserving each tissue's unique biology remains the central engineering challenge.
2026-10-06
Organoids, Organ-on-a-Chip, and the Case for Online LC–MS
Automated online LC-MS could help researchers analyze scarce, complex samples from organoid and organ-on-a-chip models.
2026-09-29
Researchers develop technology for real-time monitoring of Parkinson's treatments
A brainstem organoid chip tracks dopamine responses to Parkinson’s treatments in real time.
2026-09-28
Alabama awards $262,000 grant to upgrade forensic science equipment
Alabama will use a $262,000 grant for a biochip drug-screening analyzer and new morgue equipment.
2026-09-19
TissueGnostics collaborates with Diya Biological Technology in organoid and organ-on-a-chip innovation
TissueGnostics and Diya Biological Technology link spatial imaging with organoid and organ-on-a-chip research services.
2026-09-18
From dietary exposure to systemic toxicity: organ-on-chip and multi-organ microphysiological systems for green food toxicology
Organ-on-chip models could connect dietary exposure, metabolism, and organ injury in more human-relevant food safety tests.
2026-09-16
Qureator
Qureator develops Curiochips, a three-dimensional organ-on-chip platform for modeling human biology. The company combines engineered tissue systems with data analysis to study disease and treatment responses during preclinical drug development.
2026-09-14
DLOC Biosystems
DLOC Biosystems develops organ-on-chip devices and automated systems for connecting multiple tissue models. Its platforms combine three-dimensional scaffolds, controlled fluid handling and tissue measurements to support preclinical studies of drug effects and organ interactions.
2026-09-14
Syntopia
Syntopia combines microfluidic systems, perfused human tissue cultures and computational models to study drug responses. Its platform generates spatial and temporal measurements from three-dimensional models, with a focus on evaluating antibody-drug conjugates before clinical testing.
2026-09-14
TissUse
TissUse develops HUMIMIC multi-organ-chip systems that connect human tissue models under controlled conditions. Its platforms and research services support investigations of compound metabolism, toxicity and interactions between organs during preclinical testing.
2026-09-14
NanoCellect
NanoCellect develops microfluidic flow-cytometry instruments for analyzing and sorting cells. Its WOLF platform uses disposable microfluidic cartridges to support single-cell research, cell-line development and other experiments that need selected populations of viable cells.
2026-09-14
Nicoya
Nicoya develops biosensing instruments for studying how molecules bind and interact. Its Alto platform combines digital microfluidics with surface plasmon resonance, allowing researchers to characterize molecular interactions using small samples in automated assay workflows.
2026-09-14